Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Positron-Emission Tomography Medicine & Life Sciences
Radiopharmaceuticals Medicine & Life Sciences
Glutamate Carboxypeptidase II Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Urea Medicine & Life Sciences
Imaging techniques Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2017

A PSMA-targeted theranostic agent for photodynamic therapy

Chen, Y., Chatterjee, S., Lisok, A., Minn, I., Pullambhatla, M., Wharram, B., Wang, Y., Jin, J., Bhujwalla, Z. M., Nimmagadda, S., Mease, R. C. & Pomper, M. G. Feb 1 2017 In : Journal of Photochemistry and Photobiology B: Biology. 167, p. 111-116 6 p.

Research output: Contribution to journalArticle

Photochemotherapy
antigens
therapy
membranes
tumors

(2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido)pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy

Kiess, A. P., Minn, I., Vaidyanathan, G., Hobbs, R. F., Josefsson, A., Shen, C., Brummet, M., Chen, Y., Choi, J., Koumarianou, E., Baidoo, K., Brechbiel, M. W., Mease, R. C., Sgouros, G., Zalutsky, M. R. & Pomper, M. G. Oct 1 2016 In : Journal of Nuclear Medicine. 57, 10, p. 1569-1575 7 p.

Research output: Contribution to journalArticle

Alpha Particles
Radiopharmaceuticals
Acids
Neoplasm Micrometastasis
Therapeutics

[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma

Minn, I., Koo, S. M., Lee, H. S., Brummet, M., Rowe, S. P., Gorin, M. A., Sysa-Shah, P., Lewis, W. D., Ahn, H. H., Wang, Y., Banerjee, S. R., Mease, R. C., Nimmagadda, S., Allaf, M. E., Pomper, M. G. & Yang, X. 2016 In : Oncotarget. 7, 35, p. 56471-56479 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Positron-Emission Tomography
Ligands
Neoplasms
Kidney
Pharmacopoeias
Quality Control
human glutamate carboxypeptidase II
Quality control
Specifications
Castration
Prostatic Neoplasms
Hormones
Injections
human glutamate carboxypeptidase II